United Asset Strategies’s IN8bio INAB Stock Holding History

United Asset Strategies’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-467	Closed	-$28K	–	229
2022 Q3	$28K	Buy	+467	New	+$31.4K	﹤0.01%	202

Other funds holding INAB

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

RCG

Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

United Asset Strategies's INAB Position: Q4 2022 in Review

United Asset Strategies sold out of IN8bio (INAB) in Q4 2022, closing a stake of 467 shares — an estimated $28K sold.

United Asset Strategies first reported a position in INAB in Q3 2022 and held it in 1 quarter. The position peaked at $28K in Q3 2022. 16 funds tracked by Wall St. Rank hold INAB as of Q4 2022.

United Asset Strategies reported no remaining IN8bio position as of Q4 2022 after selling out during the quarter.
United Asset Strategies sold 467 IN8bio shares in Q4 2022, an estimated $28K.
United Asset Strategies first reported a position in IN8bio in Q3 2022 and held it in 1 quarter.
United Asset Strategies's IN8bio position peaked at $28K in Q3 2022.
16 funds tracked by Wall St. Rank held IN8bio as of Q4 2022.

Based on United Asset Strategies's 13F filing for Q4 2022, filed 26 Jan 2023.